A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps
Conditions
- Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Interventions
- DRUG: Dupilumab SAR231893 (REGN668)
- DRUG: Placebo
- DRUG: Mometasone furoate 50 micrograms
Sponsor
Sanofi
Collaborators